Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-08-2014 | Retinal Disorders

Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy

Authors: Akira Obana, Yuko Gohto, Masaki Tanito, Shigetoshi Okazaki, Werner Gellermann, Paul S. Bernstein, Akihiro Ohira

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 8/2014

Abstract

Background

Macular pigment is a defense system against phototoxic damage of the retina by visible light. It is still under debate whether or not macular pigment optical density (MPOD) levels decline with age, because the age effect varied depending on the technique used to measure MPOD levels. Resonance Raman spectroscopy (RRS) is an objective method to measure MPOD, and studies using RRS showed a drastic age-related decline of MPOD levels; however, since RRS measurements are influenced by cataracts, it has been argued that the age-related decline of RRS measurements is an artifact from lens changes in aged subjects. In the present study, MPOD levels were measured with RRS in pseudophakic eyes, and the effects of age and other factors on MPOD levels were investigated.

Methods

The subjects included 144 patients with no fundus disorders who received cataract surgery with untinted intraocular lens implantation. MPOD levels were measured in 144 eyes using integral RRS 1 day post surgery. Factors potentially associated with MPOD levels such as age, gender, smoking habits, body mass index, diabetes, glaucoma, axial length, pupil diameter, spherical equivalent refractive error, and foveal thickness were examined by multiple regression analysis.

Results

The macular pigment RRS levels ranged from 776 to 11,815 Raman counts, with an average level of 4,375 ± 1,917 (standard deviation [SD]) Raman counts. Multiple regression analysis revealed that age and axial length were significantly correlated with low MPOD values (regression coefficient of −59 for age and −404 for axial length, respectively). No significant correlations were observed for other factors.

Conclusions

After removing the potentially confounding effect of age-related lens yellowing on the RRS measurements, age remained a significant patient parameter for lowered MPOD levels. MPOD levels were found to decline by more than 10 % each decade. Axial length was also a negative predictor of MPOD levels. Since the present study included only patients aged 50 years and older, the effects of age and other factors on MPOD levels for younger subjects remain unknown.

Krinsky NI, Landrum JT, Bone RA (2003) Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 23:171–201PubMedCrossRef

Nolan JM, Stringham JM, Beatty S, Snodderly DM (2008) Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci 49:2134–2142PubMedCrossRef

Nolan JM, Stack J, O’Donovan O, Loane E, Beatty S (2007) Risk factors for age-related macular degeneration are associated with a relative lack of macular pigment. Exp Eye Res 84:61–74PubMedCrossRef

Hammond BR Jr, Caruso-Avery M (2000) Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41:1492–1497PubMed

Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 18:1212–1230PubMedCrossRef

Hammond BR Jr, Curran-Celentano J, Judd S, Fuld K, Krinsky NI, Wooten BR, Snodderly DM (1996) Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vis Res 36:2001–2012PubMedCrossRef

Broekmans WM, Berendschot TT, Klöpping-Ketelaars IA, de Vries AJ, Goldbohm RA, Tijburg LB, Kardinaal AF, van Poppel G (2002) Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr 76:595–603PubMed

Mellerio J, Ahmadi-Lari S, van Kuijk F, Pauleikhoff D, Bird A, Marshall J (2002) A portable instrument for measuring macular pigment with central fixation. Curr Eye Res 25:37–47PubMedCrossRef

Li B, Vachali P, Bernstein PS (2010) Human ocular carotenoid-binding proteins. Photochem Photobiol Sci 9:1418–1425PubMedCentralPubMedCrossRef

10.

Meyers KJ, Johnson EJ, Bernstein PS, Iyengar SK, Engelman CD, Karki CK, Liu Z, Igo RP Jr, Truitt B, Klein ML, Snodderly DM, Blodi BA, Gehrs KM, Sarto GE, Wallace RB, Robinson J, LeBlanc ES, Hageman G, Tinker L, Mares JA (2013) Genetic determinants of macular pigments in women of the carotenoids in age-related eye disease Study. Invest Ophthalmol Vis Sci 54:2333–2345PubMedCentralPubMedCrossRef

11.

Hammond CJ, Liew SH, Van Kuijk FJ, Beatty S, Nolan JM, Spector TD, Gilbert CE (2012) The heritability of macular response to supplemental lutein and zeaxanthin: a classical twin study. Invest Ophthalmol Vis Sci 53:4963–4968PubMedCentralPubMedCrossRef

12.

Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 42:235–240PubMed

13.

Bernstein PS, Zhao D-Y, Wintch SW, Ermakov IV, McClane RW, Gellermann W (2002) Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109:1780–1787PubMedCentralPubMedCrossRef

14.

Berendschot TTJM, Willemse-Assink JJM, Bastiaanse M, de Jong PT, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928–1932PubMed

15.

Obana A, Hiramistu T, Gohto Y, Ohira A, Mizuno S, Hirano T, Bernstein PS, Fujii H, Iseki K, Tanito M, Hotta Y (2008) Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population. Ophthalmology 115:147–157PubMedCrossRef

16.

Neelam K, Nolan J, Loane E, Stack J, O’Donovan O, Au Eong KG, Beatty S (2006) Macular pigment and ocular biometry. Vis Res 46:2149–2156PubMedCrossRef

17.

Neelam K, O’Gorman N, Nolan J, O’Donovan O, Wong HB, Au Eong KG, Beatty S (2005) Measurement of macular pigment: Raman spectroscopy versus heterochromatic flicker photometry. Invest Ophthalmol Vis Sci 46:1023–1032PubMedCrossRef

18.

Werner JS, Donnelly SK, Kliegl R (1987) Aging and human macular pigment density. Appended with translations from the work of Max Schultze and Ewald Hering. Vis Res 27:257–268PubMedCrossRef

19.

Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–446PubMed

20.

Nolan J, O’Donovan O, Kavanagh H, Stack J, Harrison M, Muldoon A, Mellerio J, Beatty S (2004) Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci 45:3940–3950PubMedCrossRef

21.

Kilbride PE, Alexander KR, Fishman M, Fishman GA (1989) Human macular pigment assessed by imaging fundus reflectometry. Vis Res 29:663–674PubMedCrossRef

22.

Chen SF, Chang Y, Wu JC (2001) The spatial distribution of macular pigment in humans. Curr Eye Res 23:422–434PubMedCrossRef

23.

Wüstemeyer H, Moessner A, Jahn C, Wolf S (2003) Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol 241:647–651PubMedCrossRef

24.

Berendschot TT, van Norren D (2005) On the age dependency of the macular pigment optical density. Exp Eye Res 81:602–609PubMedCrossRef

25.

Sharifzadeh M, Bernstein PS, Gellermann W (2006) Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions. J Opt Soc Am A Opt Image Sci Vis 23:2373–2387PubMedCentralPubMedCrossRef

26.

Gellermann W, Ermakov IV, Ermakova MR, McClane RW, Zhao DY, Bernstein PS (2002) In vivo resonant Raman measurement of macular carotenoid pigments in the young and the aging human retina. J Opt Soc Am A Opt Image Sci Vis 19:1172–1186PubMedCrossRef

27.

Howells O, Eperjesi F, Bartlett H (2011) Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol 249:315–347PubMedCrossRef

28.

Hogg RE, Anderson RS, Stevenson MR, Zlatkova MB, Chakravarthy U (2007) In vivo macular pigment measurements: a comparison of resonance Raman spectroscopy and heterochromatic flicker photometry. Br J Ophthalmol 91:485–490PubMedCentralPubMedCrossRef

29.

Bernstein PS, Gellermann W (2002) Measurement of carotenoids in the living primate eye using resonance raman spectroscopy. Methods Mol Biol 196:321–329PubMed

30.

Ermakov I, Ermakova M, Gellermann W, Bernstein PS (2004) Macular pigment raman detector for clinical applications. J Biomed Opt 9:139–148PubMedCentralPubMedCrossRef

31.

Tanito M, Okuno T, Ishiba Y, Ohira A (2012) Measurements of transmission spectrums and estimation of retinal blue-light irradiance values of currently available clear and yellow-tinted intraocular lenses. Jpn J Ophthalmol 56:82–90PubMedCrossRef

32.

Obana A, Tanito M, Gohto Y, Gellermann W, Okazaki S, Ohira A (2011) Macular pigment changes in pseudophakic eyes quantified with resonance Raman spectroscopy. Ophthalmology 118:1852–1858PubMedCrossRef

33.

Tanito M, Obana A, Gohto Y, Okazaki S, Gellermann W, Ohira A (2012) Macular pigment density changes in Japanese individuals supplemented with lutein or zeaxanthin: quantification via resonance Raman spectroscopy and autofluorescence imaging. Jpn J Ophthalmol 56:488–496PubMedCrossRef

34.

Hammond BR Jr, Ciulla TA, Snodderly DM (2002) Macular pigment density is reduced in obese subjects. Invest Ophthalmol Vis Sci 43:47–50PubMed

35.

Davies NP, Morland AB (2002) Color matching in diabetes: optical density of the crystalline lens and macular pigments. Invest Ophthalmol Vis Sci 43:281–289PubMed

36.

Lima VC, Rosen RB, Maia M, Prata TS, Dorairaj S, Farah ME, Sallum J (2010) Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study. Invest Ophthalmol Vis Sci 51:5840–5845PubMedCrossRef

37.

Han IC, Jaffe GJ (2009) Comparison of spectral- and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes. Am J Ophthalmol 147:847–858PubMedCrossRef

38.

Liew SH, Gilbert CE, Spector TD, Mellerio J, Van Kuijk FJ, Beatty S, Fiyzke F, Marshall J, Hammond CJ (2006) Central retinal thickness is positively correlated with macular pigment optical density. Exp Eye Res 82:915–920PubMedCrossRef

39.

Bone RA, Landrum JT, Dixon Z, Chen Y, Llerena CM (2000) Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res 71:239–245PubMedCrossRef

40.

Curran-Celentano J, Hammond BR Jr, Ciulla TA, Cooper DA, Pratt LM, Danis RB (2001) Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 74:796–802PubMed

41.

Bernstein PS, Ahmed F, Liu A, Allman S, Sheng X, Sharifzadeh M, Ermakov I, Gellermann W (2012) Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center. Invest Ophthalmol Vis Sci 53:6178–6186PubMedCentralPubMedCrossRef

Title: Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy
Authors: Akira Obana
Yuko Gohto
Masaki Tanito
Shigetoshi Okazaki
Werner Gellermann
Paul S. Bernstein
Akihiro Ohira
Publication date: 01-08-2014
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 8/2014
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-014-2574-x

At a glance: The STEP trials

Springer Medicine

Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2014

Orbicularis oculi muscle transposition for repairing involutional lower eyelid entropion

Corneal biomechanical properties after LASIK, ReLEx flex, and ReLEx smile by Scheimpflug-based dynamic tonometry

Aflibercept for inflammatory choroidal neovascularization with persistent fluid on intravitreal ranibizumab therapy

A simple computer program to quantify red desaturation in patients with optic neuritis

Increased intravitreous interleukin-18 correlated to vascular endothelial growth factor in patients with active proliferative diabetic retinopathy

The New Visual Neurosciences. Eds: John S. Werner and Leo M. Chalupa ISBN-13: 978-0-262-01916-3 The MIT Press